Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L

Clinical trial NCT02232490 · UNKNOWN

Trial details

NCT number: NCT02232490
Sponsor: Immunitor LLC
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma HCC Liver Cancer

Start date: 2015-01-01
Primary completion: 2019-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.